(NasdaqGM:OCUL), BEDFORD, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced it has received written agreement regarding a registrational trial design from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the Company's planned […]

(NASDAQ:ADVM), – ARTEMIS Phase 3 trial enrollment exceeding expectations; driven by strong retina specialist and patient enthusiasm for a potential One And Done(TM) therapy for wet AMD – ARTEMIS enrollment completion expected in 1Q 2026, with topline data anticipated 1H 2027 – LUNA 2-year long-term follow-up data planned in 4Q 2025 – Announced $10 million

(NYSE:ARR),(NYSE:ARR-PA),(NYSE:ARR-PACL),(NYSE:ARR-PB),(NYSE:ARR-PRB),(NYSE:ARR-PRC),(NYSE:ARR-PC), VERO BEACH, Florida, Aug. 12, 2025 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced that as of August 8, 2025, the Company estimated that book value per common share was approximately $17.02. Certain Tax Matters ARMOUR has elected to be taxed as a real estate

The feature will soon roll out in the Blockchain.com wallet and is designed to answer general questions without storing your chat history on our server Editor's Note: The following press release was written by June after being prompted to introduce itself to the world. Blockchain.com, one of the world's most trusted and earliestcrypto platforms, announced

(NYSE MKT:SRXH), TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc. (“SRx Canada”) and certain of its subsidiaries has sought creditor protection in Canada under the Companies' Creditors Arrangement Act,

TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) — Canadian Chartered Professional Accountants (CPAs) are earning more than ever before, with compensation growth outpacing inflation and doubling that of the broader workforce, according to new data from CPA Canada. The 2025 CPA Compensation Study, conducted by Leger, reports CPAs earned a national median compensation of $154,000 in

(TSX:UNI),(OTC US:USYNF),(Other OTC:USYNF), TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX:”UNI”) (OTC:”USYNF“) today announced strong operating results for the three months ended June 30, 2025, highlighted by continued profitability, significant gross margin gains, and disciplined cost management. For the quarter, Unisync delivered net income before tax of $1.8 million ($0.10 per share)

(NASDAQ:TLRY),(TSX:TLRY), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: Fizzy Jane's and Happy Flower. Fizzy Jane's, the sparkling seltzer line that debuted this spring in

(TSX-V:ROCK),(OTC US:TRDTF),(OTCQB:TRDTF), Vancouver, BC, Aug. 12, 2025 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company“) is pleased to announce that it has signed a non-arm's length agreement (the “Agreement“) with Eagle Plains Resources Ltd. (“Eagle Plains” or “EPL“) pursuant to which the Company has acquired a 100% interest in

(NASDAQ:KRRO), — Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD) cohorts with no treatment emergent serious adverse events (SAEs) or dose limiting toxicities observed — European Medicines Agency